Preface of the Special Issue “COVID-19 Infection and Hematological Malignancies”

por Chen, Mingyi, Anderson, Larry D.
Publicado 2022

Editorial: T-cell directed therapies in multiple myeloma

por Richter, Joshua, Anderson, Larry D., Ramasamy, Karthik, Rossi, Adriana
Publicado 2023

Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19

por Zheng, Ruifang, Mieth, Kelsey, Bennett, Christen, Miller, Carol, Anderson, Larry D., Chen, Mingyi, Cao, Jing
Publicado 2023

Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians

por Banerjee, Rahul, Wang, Bo, Anderson, Larry D., McCaughan, Georgia, Mehra, Nikita, Cowan, Andrew J., Rajkumar, S. Vincent, Kaur, Gurbakhash
Publicado 2023

Cardiovascular disease and chimeric antigen receptor cellular therapy

por Rao, Anjali, Stewart, Andrew, Eljalby, Mahmoud, Ramakrishnan, Praveen, Anderson, Larry D., Awan, Farrukh T., Chandra, Alvin, Vallabhaneni, Srilakshmi, Zhang, Kathleen, Zaha, Vlad G.
Publicado 2022

P932: PATIENT PERSPECTIVES ON BCMA-TARGETED THERAPIES FOR MULTIPLE MYELOMA: A SURVEY CONDUCTED IN A PATIENT ADVOCACY GROUP

por Hydren, Jay R., Lin, Dee, Arturo Hurtado, Jorge, Sweeney, Nathan W., Wu, Bingcao, Gries, Katharine, Kim, Nina, Patel, Saurabh, Sborov, Douglas W., Berdeja, Jesus, Anderson, Larry D., Stephen Huo, Jinhai, Ahlstrom, Jennifer M.
Publicado 2023

S193: BMS-986393 (CC-95266), A G PROTEIN–COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)–TARGETED CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FRO...

por Bal, Susan, Berdeja, Jesus, Htut, Myo, Kocoglu, Mehmet, Gregory, Tara, Anderson, Larry D., Rossi, Adriana, Egan, Daniel, Costa, Luciano, Kelly, Lisa, Ziyad, Safiyyah, Hu, Hongxiang, Chen, Yanping, Kaeding, Allison J., Burgess, Michael, Hege, Kristen, Nadeem, Omar
Publicado 2023

COVID Vaccine Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Better Antibody Response in Patients with Myeloid Malignancies Than B-Cel...

por Goksu, Suleyman Y, Rolwes, John, Premnath, Naveen, Patel, Prapti, Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Ramakrishnan, Praveen, Kansagra, Ankit, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Chung, Stephen, Madanat, Yazan F.
Publicado 2021

KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

por Jagannath, Sundar, Lin, Yi, Goldschmidt, Hartmut, Reece, Donna, Nooka, Ajay, Senin, Alicia, Rodriguez-Otero, Paula, Powles, Ray, Matsue, Kosei, Shah, Nina, Anderson, Larry D., Streetly, Matthew, Wilson, Kimberly, Le, Hoa Van, Swern, Arlene S., Agarwal, Amit, Siegel, David S.
Publicado 2021

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

por Chari, Ajai, Cornell, Robert F., Gasparetto, Cristina, Karanes, Chatchada, Matous, Jeffrey V., Niesvizky, Ruben, Lunning, Matthew, Usmani, Saad Z., Anderson, Larry D., Chhabra, Saurabh, Girnius, Saulius, Shustik, Chaim, Stuart, Robert, Lee, Yihua, Salman, Zeena, Liu, Emily, Valent, Jason
Publicado 2020

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

por Sannareddy, Aishwarya, Reves, Heather, Jaleta, Kefyalew, .Ramiahsankarasubramanian, Ramyakumari, Patel, Hetalkumari, Narasimhan, Madhusudhanan, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen S., Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T., Muthukumar, Alagarraju, Ramakrishnan Geethakumari, Praveen
Publicado 2022

‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies

por Sannareddy, Aishwarya, Reves, Heather, Narasimhan, Madhusudhanan, Jaleta, Kefyalew, Anderson, Julia Marie, Patel, Hetalkumari, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen, Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T, Muthukumar, Alagar R, Geethakumari, Praveen Ramakrishnan
Publicado 2023

SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation

por Hoff, Fieke W., Goksu, Suleyman Y., Premnath, Naveen, Patel, Prapti A., Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Geethakumari, Praveen Ramakrishnan, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Weinberg, Olga K., Muthukumar, Alagarraju, Chung, Stephen S., Madanat, Yazan F.
Publicado 2023

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

por Dimopoulos, Meletios, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, San-Miguel, Jesus, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Casal, Eva, Srinivasan, Shankar, Yu, Xin, Nguyen, Tuong Vi, Biyukov, Tsvetan, Peluso, Teresa, Richardson, Paul
Publicado 2020

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

por Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laubach, Jacob P., Stockerl‐Goldstein, Keith E., Kwei, Long, Clow, Fong, Elias, Laurence, Salman, Zeena, Graef, Thorsten, Bilotti, Elizabeth, Vij, Ravi
Publicado 2018

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

por Nooka, Ajay K., Kaufman, Jonathan L., Rodriguez, Cesar, Jakubowiak, Andrzej, Efebera, Yvonne, Reeves, Brandi, Wildes, Tanya, Holstein, Sarah A., Anderson, Larry D., Badros, Ashraf, Shune, Leyla, Chari, Ajai, Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Richardson, Paul G., Voorhees, Peter
Publicado 2022

Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma

por Kansagra, Ankit, Dispenzieri, Angela, Fraser, Raphael, Estrada-Merly, Noel, Sidana, Surbhi, Nishihori, Taiga, Hansen, Doris K., Anderson, Larry D., Banerjee, Rahul, Bumma, Naresh, Dhakal, Binod, Khouri, Jack, Landau, Heather, Lee, Cindy, Mian, Hira, Nathan, Sunita, Savani, Bipin, Kumar, Shaji, Qazilbash, Muzaffar, Shah, Nina, D’Souza, Anita
Publicado 2022

Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study

por Sborov, Douglas W., Baljevic, Muhamed, Reeves, Brandi, Laubach, Jacob, Efebera, Yvonne A., Rodriguez, Cesar, Costa, Luciano J., Chari, Ajai, Silbermann, Rebecca, Holstein, Sarah A., Anderson, Larry D., Kaufman, Jonathan L., Shah, Nina, Pei, Huiling, Patel, Sharmila, Cortoos, Annelore, Bartlett, J. Blake, Vermeulen, Jessica, Lin, Thomas S., Voorhees, Peter M., Richardson, Paul G.
Publicado 2022

Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide‐pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics

por Richardson, Paul G., Schjesvold, Fredrik, Weisel, Katja, Moreau, Philippe, Anderson, Larry D., White, Darrell, Rodriguez‐Otero, Paula, Sonneveld, Pieter, Engelhardt, Monika, Jenner, Matthew, Corso, Alessandro, Dürig, Jan, Pavic, Michel, Salomo, Morten, Beksac, Meral, Oriol, Albert, Lindsay, Jindriska, Liberati, Anna Marina, Galli, Monica, Robak, Pawel, Larocca, Alessandra, Yagci, Munci, Vural, Filiz, Kanate, Abraham S., Jiang, Ruiyun, Grote, Lara, Peluso, Teresa, Dimopoulos, Meletios
Publicado 2021

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

por Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., Castaneda Puglianini, Omar Alexis
Publicado 2023